Alere to Develop Simple, Affordable Point-of-Care Nucleic Acid Test for Tuberculosis & Expand Manufacturing for POC HIV Viral Load Platform WALTHAM, Mass., March 1, 2013 /PRNewswire/ -- Alere Inc.

Tuberculosis is now a significant public health issue, and nurses need to know its signs and symptoms and which groups at increased risk of infection Tuberculosis has re-emerged as a significant ...

Even as high-income countries roll out Covid-19 vaccine boosters and stockpile millions of vaccine doses, many low- and middle-income countries are struggling to obtain vaccines. Whereas 76% of people ...

The $21.6 million grant will fund the development of a tuberculosis assay, which will be designed for use in both resource-constrained and well-resourced settings. It will also support the company’s ...

Tuberculosis is a serious lung infection caused by germs that spread via the air. Despite advances in medical therapy to cure tuberculosis, prevention remains the best strategy. Dr. Shweta Bansal, ...